[
  {
    "ts": null,
    "headline": "Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy)",
    "summary": "Zoetis leads in animal health with strong EPS growth, key patent-protected drugs, and a rare value entry point. Learn why ZTS stock is upgraded to strong buy.",
    "url": "https://finnhub.io/api/news?id=02e78cf42d29f2da0a70b14a2648f4febbdc001636b97ca5b51a7f0adef87176",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752831011,
      "headline": "Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy)",
      "id": 136001411,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1661329207/image_1661329207.jpg?io=getty-c-w1536",
      "related": "IDXX",
      "source": "SeekingAlpha",
      "summary": "Zoetis leads in animal health with strong EPS growth, key patent-protected drugs, and a rare value entry point. Learn why ZTS stock is upgraded to strong buy.",
      "url": "https://finnhub.io/api/news?id=02e78cf42d29f2da0a70b14a2648f4febbdc001636b97ca5b51a7f0adef87176"
    }
  }
]